WeVote
Log In

Bill

Bill

A 5341

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

2024-2025 Regular Session Introduced by Linda Carter and 3 co-sponsors

New Jersey bill mandates health insurance cover Alzheimer's disease screening for eligible residents, improving early detection access while raising questions about costs and clinical necessity standards.

Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
#disease #healthinsur
0
WeVote Research Nonpartisan
Bill Summary · A 5341

Legislative bill overview

Assembly Bill A5341 mandates that health insurance plans in New Jersey cover screening and diagnostic testing for Alzheimer's disease and related cognitive disorders for eligible covered persons. The bill specifies which populations would qualify for this coverage requirement and establishes standards for what screening services must be included.

Why is this important

Alzheimer's disease and related dementias affect approximately 6 million Americans, with early detection potentially enabling earlier intervention and care planning. Requiring insurance coverage removes financial barriers to screening, which could lead to earlier diagnosis and allow families and individuals to prepare medically and financially before symptoms progress significantly.

Potential points of contention

  • Cost implications: Insurers and employer-sponsored plans may argue that mandated coverage increases premiums for all policyholders, while supporters contend early detection reduces long-term care costs
  • Medical necessity debate: Questions remain about which screening methods are clinically validated, who should be screened (age thresholds, risk factors), and whether routine screening is appropriate versus targeted screening for symptomatic individuals
  • Scope of coverage: The bill's specificity regarding "certain covered persons" may be unclear—whether coverage extends to all age groups, family history requirements, or whether asymptomatic screening is included affects both access and costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.